Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer
    Journal Article

    Joshi, S.; Gomes, E. D.; Wang, T.; Corben, A.; Taldone, T.; Gandu, S.; Xu, C.; Sharma, S.; Buddaseth, S.; Yan, P.; more...
    Communications Biology (2021)

    Fulltext@MSK | Save
  • Predictors of recurrence in non-metastatic appendiceal cancer: A single center experience over 25 years
    Meeting Abstract

    Chung, S.; Shia, J.; Cercek, A.; Nash, G.
    Journal of the American College of Surgeons (2021)

    Fulltext@MSK | Save
  • Final results from ClarIDHy, a global, phase 3, randomized, double-blind study of ivosidenib (IVO) versus placebo (PBO) in patients (pts) with previously treated cholangiocarcinoma (CCA) and an isocitrate dehydrogenase 1 (IDH1) mutation
    Meeting Abstract

    Abou-Alfa, G. K.; Macarulla, T.; Javle, M. M.; Kelley, R. K.; Lubner, S. J.; Adeva, J.; Cleary, J. M.; Catenacci, D. V. T.; Borad, M. J.; Bridgewater, J. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinicopathological and molecular characteristics of early-onset stage III colon adenocarcinoma: An analysis of 25 studies with 35,713 patients in the Adjuvant Colon Cancer End Points (ACCENT) database
    Meeting Abstract

    Jin, Z.; Dixon, J. G.; Parekh, H.; Sinicrope, F. A.; Yothers, G.; Haller, D. G.; Schmoll, H.; De Gramont, A.; Kerr, R.; Taieb, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Final overall survival for the phase III KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Andre, T.; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D. M.; Garcia-Carbonero, R.; Alcaide, J.; Gibbs, P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study
    Meeting Abstract

    Janjigian, Y. Y.; Kawazoe, A.; Yanez, P. E.; Luo, S.; Lonardi, S.; Kolesnik, O.; Barajas, O.; Bai, Y.; Shen, L.; Tang, Y.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Dietary fat in relation to overall and progression-free survival among patients (pts) with advanced or metastatic colorectal cancer (CRC): Data from CALGB 80405 (Alliance)
    Meeting Abstract

    Van Blarigan, E.; Ma, C.; Ou, F. S.; Venook, A. P.; Ng, K.; Niedzwiecki, D.; Giovannucci, E. L.; Lenz, H. J.; Innocenti, F.; Shaw, J. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pemigatinib for previously treated locally advanced/metastatic cholangiocarcinoma (CCA): Update of FIGHT-202
    Meeting Abstract

    Abou-Alfa, G. K.; Sahai, V.; Hollebecque, A.; Vaccaro, G. M.; Melisi, D.; Al-Rajabi, R. M. T.; Paulson, A. S.; Borad, M. J.; Gallinson, D. H.; Murphy, A. G.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649
    Meeting Abstract

    Moehler, M. H.; Shitara, K.; Garrido, M.; Salman, P.; Shen, L.; Wyrwicz, L.; Yamaguchi, K.; Skoczylas, T.; Bragagnoli, A. S. C.; Liu, T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405
    Meeting Abstract

    DiNardo, K.; Ma, C.; Ou, F. S.; Yuan, C.; Guercio, B. J.; Morales-Oyarvide, V.; Van Blarigan, E.; Niedzwiecki, D.; Chang, I. W.; Lenz, H. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save